February 27, 2026 a 09:01 pm
BAX: Analysts Ratings - Baxter International Inc.
Baxter International Inc., with its diversified healthcare products, has a wide footprint in global markets. Despite its robust portfolio and innovative collaborations, the recent analyst sentiment indicates a conservative stance. The prevailing Hold ratings suggest cautious optimism amidst the changing healthcare landscape, while the limited Strong Buy assessments denote a sense of cautious market confidence.
Historical Stock Grades
| Rating | Number | Score Bar |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 2 | |
| Hold | 13 | |
| Sell | 1 | |
| Strong Sell | 0 |
Sentiment Development
Over the past several months, the sentiment around BAX has exhibited notable shifts. A stable increase in Hold ratings contrasts with a decline in Buy levels since mid-2025. While Strong Buy ratings remain scarce, a persistent trend toward neutrality is evident.
- The number of Hold ratings climbed steadily from the previous values.
- Strong Buy recommendations have decreased from their relative peak in 2024.
- This shift suggests cautious sentiment in the face of broader market conditions.
Percentage Trends
Analysis of the rating percentages reveals significant realignment. The reduction in Strong Buy positions correlates with an increase in conservative Hold views. An examination of the timeline shows:
- As of February 2026, Hold recommendations account for 65% of all ratings, up from just 30% previously.
- Buy recommendations have slightly dimmed, now representing 10% of the total.
- The shift towards Hold points to a more reserved outlook on BAX's immediate market performance.
The most striking change is the rise in Hold ratings, a clear indicator of adjusted expectations and moderated investor enthusiasm over the past year.
Latest Analyst Recommendations
The latest recommendations reflect a conservative hold pattern. Despite diverse industry collaborations and strategic initiatives by Baxter, analysts have consistently maintained their ratings.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-02-17 | Neutral | Neutral | Goldman Sachs |
| 2026-02-13 | Overweight | Overweight | Barclays |
| 2026-01-09 | Overweight | Overweight | Barclays |
| 2025-12-02 | Underweight | Underweight | Morgan Stanley |
| 2025-10-31 | Neutral | Neutral | Citigroup |
Analyst Recommendations with Change of Opinion
In recent months, several analysts have adjusted their stance. While some downgraded their recommendations, others reflected on broader economic indicators and Baxter's strategic pivots.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-31 | Hold | Buy | Argus Research |
| 2025-08-04 | Hold | Buy | Stifel |
| 2024-07-15 | Underweight | Equal Weight | Morgan Stanley |
| 2024-05-10 | Hold | Buy | TD Cowen |
| 2023-01-06 | Equal Weight | Overweight | Morgan Stanley |
Interpretation
The current data suggests a market outlook characterized by caution. Analysts have adjusted their recommendations towards more conservative stances, reflecting uncertainty in growth prospects for Baxter amidst economic volatility. There is a discernible retreat from aggressive positions to more conservative Hold recommendations. Trust in the stock appears tempered, with analysts preferring to await clearer indicators of market recovery before revising their stance.
Conclusion
In summary, while Baxter International Inc. continues to innovate and maintain a diversified portfolio, analyst sentiment remains cautious. The trend toward increased Hold ratings underscores a moderated confidence in Baxter's immediate growth potential facing a fluctuating market environment. Analysts seem wary of external factors impacting the healthcare sector and are holding back from aggressive Buy recommendations. As such, potential investors may consider monitoring market shifts closely before taking action. Despite these challenges, Baxter's long-standing market position might eventually offer upside opportunities once global economic stability improves.